Literature DB >> 21285357

Protein-arginine methyltransferase 1 (PRMT1) methylates Ash2L, a shared component of mammalian histone H3K4 methyltransferase complexes.

Jill S Butler1, Cecilia I Zurita-Lopez, Steven G Clarke, Mark T Bedford, Sharon Y R Dent.   

Abstract

Multiple enzymes and enzymatic complexes coordinately regulate the addition and removal of post-translational modifications on histone proteins. The oncoprotein Ash2L is a component of the mixed lineage leukemia (MLL) family members 1-4, Setd1A, and Setd1B mammalian histone H3K4 methyltransferase complexes and is essential to maintain global trimethylation of histone H3K4. However, regulation of these complexes at the level of expression and activity remains poorly understood. In this report, we demonstrate that Ash2L is methylated on arginine residues both in vitro and in cells. We found that both protein-arginine methyltransferases 1 and 5 methylate Arg-296 within Ash2L. These findings are the first to demonstrate that post-translational modifications occur on the Ash2L protein and provide a novel example of cross-talk between chromatin-modifying enzyme complexes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285357      PMCID: PMC3069427          DOI: 10.1074/jbc.M110.202416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena.

Authors:  B D Strahl; R Ohba; R G Cook; C D Allis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.

Authors:  H Makishima; A M Jankowska; R V Tiu; H Szpurka; Y Sugimoto; Z Hu; Y Saunthararajah; K Guinta; M A Keddache; P Putnam; M A Sekeres; A R Moliterno; A F List; M A McDevitt; J P Maciejewski
Journal:  Leukemia       Date:  2010-08-19       Impact factor: 11.528

3.  Cross-regulation of histone modifications.

Authors:  John A Latham; Sharon Y R Dent
Journal:  Nat Struct Mol Biol       Date:  2007-11-05       Impact factor: 15.369

4.  Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.

Authors:  R D Hanson; J L Hess; B D Yu; P Ernst; M van Lohuizen; A Berns; N M van der Lugt; C S Shashikant; F H Ruddle; M Seto; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  Ash2l interacts with Tbx1 and is required during early embryogenesis.

Authors:  Jason Z Stoller; Li Huang; Cheryl C Tan; Facan Huang; Diane D Zhou; Jifu Yang; Bruce D Gelb; Jonathan A Epstein
Journal:  Exp Biol Med (Maywood)       Date:  2010-05

6.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.

Authors:  Thomas Ernst; Andrew J Chase; Joannah Score; Claire E Hidalgo-Curtis; Catherine Bryant; Amy V Jones; Katherine Waghorn; Katerina Zoi; Fiona M Ross; Andreas Reiter; Andreas Hochhaus; Hans G Drexler; Andrew Duncombe; Francisco Cervantes; David Oscier; Jacqueline Boultwood; Francis H Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

7.  Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Authors:  Gorica Nikoloski; Saskia M C Langemeijer; Roland P Kuiper; Ruth Knops; Marion Massop; Evelyn R L T M Tönnissen; Adrian van der Heijden; Theresia N Scheele; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

8.  TbPRMT6 is a type I protein arginine methyltransferase that contributes to cytokinesis in Trypanosoma brucei.

Authors:  John C Fisk; Cecilia Zurita-Lopez; Joyce Sayegh; Danielle L Tomasello; Steven G Clarke; Laurie K Read
Journal:  Eukaryot Cell       Date:  2010-04-23

9.  Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.

Authors:  Pengfei Wang; Chengqi Lin; Edwin R Smith; Hong Guo; Brian W Sanderson; Min Wu; Madelaine Gogol; Tara Alexander; Christopher Seidel; Leanne M Wiedemann; Kai Ge; Robb Krumlauf; Ali Shilatifard
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

10.  On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.

Authors:  Anamika Patel; Venkatasubramanian Dharmarajan; Valarie E Vought; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

View more
  16 in total

Review 1.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

Review 2.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

3.  PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch.

Authors:  Alexsandra B Espejo; Guozhen Gao; Karynne Black; Sitaram Gayatri; Nicolas Veland; Jeesun Kim; Taiping Chen; Marius Sudol; Cheryl Walker; Mark T Bedford
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

4.  Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.

Authors:  Jill S Butler; Yi Hua Qiu; Nianxiang Zhang; Suk-Young Yoo; Kevin R Coombes; Sharon Y R Dent; Steven M Kornblau
Journal:  Leuk Lymphoma       Date:  2016-10-13

Review 5.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

6.  The histone- and PRMT5-associated protein COPR5 is required for myogenic differentiation.

Authors:  C Paul; C Sardet; E Fabbrizio
Journal:  Cell Death Differ       Date:  2011-12-23       Impact factor: 15.828

7.  PRMT5 modulates the metabolic response to fasting signals.

Authors:  Wen-Wei Tsai; Sherry Niessen; Naomi Goebel; John R Yates; Ernesto Guccione; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

8.  Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions.

Authors:  You Feng; Ranjan Maity; Julian P Whitelegge; Andrea Hadjikyriacou; Ziwei Li; Cecilia Zurita-Lopez; Qais Al-Hadid; Amander T Clark; Mark T Bedford; Jean-Yves Masson; Steven G Clarke
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

9.  Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.

Authors:  Surbhi Dhar; Vidyasiri Vemulapalli; Alexander N Patananan; Grace L Huang; Alessandra Di Lorenzo; Stephane Richard; Michael J Comb; Ailan Guo; Steven G Clarke; Mark T Bedford
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.

Authors:  Dorothee Dormann; Tobias Madl; Chiara F Valori; Eva Bentmann; Sabina Tahirovic; Claudia Abou-Ajram; Elisabeth Kremmer; Olaf Ansorge; Ian R A Mackenzie; Manuela Neumann; Christian Haass
Journal:  EMBO J       Date:  2012-09-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.